Literature DB >> 2409934

AFP-producing Sertoli-Leydig cell tumor of the ovary.

S Sekiya, N Inaba, H Iwasawa, O Kobayashi, H Takamizawa, O Matsuzaki, K Nagao.   

Abstract

A tumor of the right ovary in a 21-year-old single woman is reported. Secondary amenorrhea, hirsutism, acne and deepening of the voice were associated with the tumor. Light and electron microscopic examinations showed that the tumor was composed of cells resembling Sertoli and Leydig cells of the testis in their cytology features and growth patterns. High levels of circulating dehydroepiandrosterone, androstenedione, testosterone and alpha-fetoprotein (AFP) were found preoperatively. Preoperative estrogen and progesterone levels were all slightly above the upper limits of normal for females. These hormone and AFP levels fell to within the normal range after removal of the tumor. Direct hormone and AFP production of this tumor was confirmed by immunohistochemical techniques and long-term cell cultures in vitro. This is possibly the first report on a Sertoli-Leydig cell tumor in which AFP has been identified in the patient's plasma, in part of the tumor cells and the culture fluid.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2409934     DOI: 10.1007/bf02133963

Source DB:  PubMed          Journal:  Arch Gynecol        ISSN: 0170-9925


  28 in total

1.  STEROID SYNTHESIS IN ABNORMAL OVARIES. 1. ARRHENOBLASTOMA.

Authors:  N KASE; S H CONRAD
Journal:  Am J Obstet Gynecol       Date:  1964-12-15       Impact factor: 8.661

2.  Formation of androgens by human arrhenoblastoma tissue in vitro.

Authors:  K SAVARD; M GUT; R I DORFMAN; J L GABRILOVE; L J SOFFER
Journal:  J Clin Endocrinol Metab       Date:  1961-02       Impact factor: 5.958

3.  Metabolism of progesterone-4-C14 by an arrhenoblastoma.

Authors:  W G WIEST; J ZANDER; E G HOLMSTROM
Journal:  J Clin Endocrinol Metab       Date:  1959-03       Impact factor: 5.958

4.  Arrhenoblastoma of the ovary. Review of the literature and report of 2 cases.

Authors:  P PEDOWITZ; F B O'BRIEN
Journal:  Obstet Gynecol       Date:  1960-07       Impact factor: 7.661

5.  Endocrine studies in an arrhenoblastoma responsive to dexamethasone, ACTH and human chorionic gonadotropin.

Authors:  J R Tucci; W Zäh; A E Kalderon
Journal:  Am J Med       Date:  1973-11       Impact factor: 4.965

6.  Arrhenoblastoma: in vivo and in vitro studies.

Authors:  E V Younglai; H Richmond; R Atyeo; F L Johnson
Journal:  Am J Obstet Gynecol       Date:  1973-06-01       Impact factor: 8.661

7.  Arrhenoblastoma: three case reports.

Authors:  R B Greenblatt; V B Mahesh; R D Gambrell
Journal:  Obstet Gynecol       Date:  1972-04       Impact factor: 7.661

8.  A clinical and metabolic study of masculinizing arrhenoblastoma.

Authors:  T Sato; T Shinada; S Matsumoto
Journal:  Am J Obstet Gynecol       Date:  1969-08-15       Impact factor: 8.661

9.  An arrhenoblastoma with estimations of androgenic steroids.

Authors:  J E Bruce
Journal:  J Obstet Gynaecol Br Commonw       Date:  1967-08

10.  An immunohistological study of steroid localization in Sertoli-Leydig tumors of the ovary and testis.

Authors:  R J Kurman; D Andrade; U Goebelsmann; C R Taylor
Journal:  Cancer       Date:  1978-10       Impact factor: 6.860

View more
  3 in total

Review 1.  Ovarian Sertoli-Leydig cell tumor with heterologous elements of gastrointestinal type associated with elevated serum alpha-fetoprotein level: an unusual case and literature review.

Authors:  Mariana Horta; Teresa Margarida Cunha; Rita Canas Marques; Ana Félix
Journal:  J Radiol Case Rep       Date:  2014-11-30

2.  α-Fetoprotein-Producing Non-Germ Cell Tumors of the Urological System.

Authors:  Mona El-Bahrawy
Journal:  Rev Urol       Date:  2011

3.  15-Year-Old Patient with an Unusual Alpha-Fetoprotein-Producing Sertoli-Leydig Cell Tumor of Ovary.

Authors:  Kaçar Serife; Stavros Karampelas; Nathalie Hottat; Christine Devalck; Katherina Vanden Houte
Journal:  Case Rep Obstet Gynecol       Date:  2022-04-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.